Dextromethorphan: A review of N-methyl-D-aspartate receptor antagonist in the management of pain

81Citations
Citations of this article
92Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Dextromethorphan (DM) is a noncompetitive N-methyl-d-aspartate (NMDA) receptor antagonist, which is widely used as an antitussive agent. DM also prevents neuronal damage and modulates pain sensation via noncompetitive antagonism of excitatory amino acids (EAAs). DM has been found to be useful in the treatment of pain in cancer patients and in the treatment of methotrexate-induced neurotoxicity. Clinical studies with DM in cancer patients are reviewed in this article. © 2007 Blackwell Publishing Inc.

Cite

CITATION STYLE

APA

Siu, A., & Drachtman, R. (2007, March). Dextromethorphan: A review of N-methyl-D-aspartate receptor antagonist in the management of pain. CNS Drug Reviews. https://doi.org/10.1111/j.1527-3458.2007.00006.x

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free